167 related articles for article (PubMed ID: 29215551)
21. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma.
Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR
Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212
[TBL] [Abstract][Full Text] [Related]
22. SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.
Davis EJ; Zhao L; Lucas DR; Schuetze SM; Baker LH; Zalupski MM; Thomas D; Chugh R
BMC Cancer; 2016 Aug; 16():663. PubMed ID: 27544129
[TBL] [Abstract][Full Text] [Related]
23. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
24. Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
Haller F; Knopf J; Ackermann A; Bieg M; Kleinheinz K; Schlesner M; Moskalev EA; Will R; Satir AA; Abdelmagid IE; Giedl J; Carbon R; Rompel O; Hartmann A; Wiemann S; Metzler M; Agaimy A
J Pathol; 2016 Apr; 238(5):700-10. PubMed ID: 26863915
[TBL] [Abstract][Full Text] [Related]
25. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
Mamillapalli S; Miyagi M; Bann JG
Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
27. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
[TBL] [Abstract][Full Text] [Related]
28. KIT activation in soft tissue sarcomas.
Tamborini E; Bonadiman L; Moiraghi L; Pilotti S; Pierotti MA
Am J Clin Pathol; 2002 Sep; 118(3):472-3; author reply 473. PubMed ID: 12219791
[No Abstract] [Full Text] [Related]
29. LHRH receptor expression in sarcomas of bone and soft tissue.
Deivaraju C; Temple HT; Block N; Robinson P; Schally AV
Horm Mol Biol Clin Investig; 2016 Nov; 28(2):105-111. PubMed ID: 27639272
[TBL] [Abstract][Full Text] [Related]
30. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
[TBL] [Abstract][Full Text] [Related]
31. Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas.
Paydas S; Bagir EK; Deveci MA; Gonlusen G
Med Oncol; 2016 Aug; 33(8):93. PubMed ID: 27421997
[TBL] [Abstract][Full Text] [Related]
32. ＜Editors' Choice＞
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Oike N; Sasaki T; Hatano H; Endo N
Nagoya J Med Sci; 2020 Feb; 82(1):85-92. PubMed ID: 32273636
[TBL] [Abstract][Full Text] [Related]
33. Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients.
Taubert HW; Bartel F; Kappler M; Schuster K; Meye A; Lautenschläger C; Thamm-Mücke B; Bache M; Schmidt H; Holzhausen HJ; Würl P
Cancer; 2003 May; 97(9):2273-8. PubMed ID: 12712483
[TBL] [Abstract][Full Text] [Related]
34. Altered patterns of RB expression define groups of soft tissue sarcoma patients with distinct biological and clinical behavior.
Polsky D; Mastorides S; Kim D; Dudas M; Leon L; Leung D; Woodruff JM; Brennan MF; Osman I; Cordon-Cardo C
Histol Histopathol; 2006 Jul; 21(7):743-52. PubMed ID: 16598673
[TBL] [Abstract][Full Text] [Related]
35. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
36. Solid tumor therapy by selectively targeting stromal endothelial cells.
Liu S; Liu J; Ma Q; Cao L; Fattah RJ; Yu Z; Bugge TH; Finkel T; Leppla SH
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4079-87. PubMed ID: 27357689
[TBL] [Abstract][Full Text] [Related]
37. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
[TBL] [Abstract][Full Text] [Related]
38. Sex Hormone-regulated
Fang Z; Killick C; Halfpenny C; Frewer N; Frewer KA; Ruge F; Jiang WG; Ye L
Cancer Genomics Proteomics; 2022; 19(6):703-710. PubMed ID: 36316045
[TBL] [Abstract][Full Text] [Related]
39. Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients.
Stein U; Jürchott K; Schläfke M; Hohenberger P
J Clin Oncol; 2002 Aug; 20(15):3282-92. PubMed ID: 12149303
[TBL] [Abstract][Full Text] [Related]
40. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Karamchandani JR; Nielsen TO; van de Rijn M; West RB
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
